The State Office of Health Strategy has approved an application for a proton therapy center for cancer in Wallingford.  This follows denial last month of Danbury Proton's application for a similar facility.  An appeal hearing is set for April 22nd in the case. 

Danbury Proton says the state’s decision on the proposed partnership between Yale New Haven Health and Hartford HealthCare systems, whose application came six months before Danbury Proton's application, was good news for the cause of proton therapy in Connecticut.  But in their appeal application, Danbury Proton says Connecticut will become the first state in the nation to affirmatively deny its cancer patients access to a life-saving technology that is proven to minimize harmful side effects and preserve the patient's quality of life.

The highly targeted radiological proton therapy delivers a more accurate dose, producing less damage to healthy surrounding tissue and fewer side effects.